41
Participants
Start Date
August 26, 2019
Primary Completion Date
August 31, 2026
Study Completion Date
February 28, 2027
Losartan
Losartan will be administered orally daily on days 1-42 (6 weeks) with dose level assignments. Dosing will be performed based on weight in kilograms and rounded to the nearest 12.5 mg (half of 25 mg tablet). Dose level 1 dosing will not exceed 50 mg daily, dose level 2 dosing will not exceed 100 mg daily, and dose level 3 dosing will not exceed 150 mg total daily (75 mg twice daily). Doses should be taken at approximately the same time daily and patients should fast for at least 4 hours prior to dosing
Sunitinib
Sunitinib will be administered orally daily on days 1-28 (4 weeks), followed by 14-day rest period (2 weeks). Dosing will be performed based on body surface area (BSA) in mg/m2. Sunitinib is given as capsules or liquid formulation. Doses should be taken at approximately the same time daily.
RECRUITING
Children's Hospital of Atlanta, Atlanta
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
University of Colorado Hospital, Aurora
NOT_YET_RECRUITING
Children's Hospital Los Angeles, Los Angeles
Cancer League of Colorado
OTHER
Colorado State University
OTHER
Swim Across America
OTHER
University of Colorado, Denver
OTHER